fluorodeoxyglucose f18 has been researched along with Teratocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, S; Hatazawa, J; Ito, E; Kashiyama, N; Kawamura, A; Kawamura, T; Masuda, S; Miyagawa, S; Morii, E; Sawa, Y; Toda, K; Watabe, T | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and Teratocarcinoma
| Article | Year |
|---|---|
Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice.
Topics: Animals; Biopsy; Cell Line; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Gene Order; Genetic Vectors; Graft Rejection; Immunocompromised Host; Immunosuppressive Agents; Induced Pluripotent Stem Cells; Male; Mice; Mice, Transgenic; Models, Animal; Myocytes, Cardiac; Positron-Emission Tomography; Stem Cell Transplantation; T-Lymphocyte Subsets; Tacrolimus; Teratocarcinoma; Transplantation, Homologous | 2016 |